Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation

Overview of attention for article published in BMC Cancer, September 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

So far, Altmetric has seen 21 X posts from 10 X users, with an upper bound of 7,689 followers.

En zou ook nog wel eens kosteneffectiever kunnen zijn dan medicatie. https://t.co/emFhp6bssO

RT @WimvanHarten: Brede technology assessment van Tumor Infiltrating Lymfocyt behandeling in J Immunotherapy https://t.co/9LczCYGvvs nadat…

RT @PANAXEA: Early #costeffectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced #melanoma: a model-base…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 17 additional X posts.